Skip to Content
We are currently studying the efficacy of one-day acceptance and commitment therapy (ACT) workshops in people suffering from depression and migraine. We are also looking into treatments involving biofeedback.
In this study we are interested in efficacy of a one-day group workshop that combines acceptance and commitment therapy (ACT) with illness management.
Some outcomes of interest are:
The importance of this study:
In this study we are looking at biofeedback devices that measure heart rate variability and help guide the patient's breathing to alter their heart rate. It is our hope that, once learned, these breathing exercises can be used to help with pain, stress, anxiety, depression, and improve overall health and quality of life.
The goal of this biofeedback device is to guide patients from a state of heart rate incoherence to coherence.
In this study we are interested in efficacy of a one-day group workshop that combines acceptance and commitment training (ACT) with illness management in those with comorbid vascular risk factors (diabetes, high blood pressure, high cholesterol, and excess weight) and depression/anxiety symptoms.
Importance of study:
Cardiovascular disease is the number one cause of death in the world. A large percentage of those with cardiovascular disease suffer from depression and/or anxiety. Studies have shown that the presence of depression and anxiety symptoms can have adverse effects on heart health. Also, the onset of heart disease can lead to an increase in depression/anxiety symptoms—even in those without prior history. Because of this bidirectional relationship, it is important to create behavioral interventions that can address both vascular risk factors as well as depression and anxiety symptoms.